Megalocornea-intellectual disability syndrome is a rare genetic condition that is usually recognized in infancy or childhood. It causes unusually large clear fronts of the eyes and developmental or learning difficulties, and some people may also have low muscle tone, delayed speech, or problems with coordination. The early signs of Megalocornea-intellectual disability syndrome can vary, so not everyone will have the same experience. Megalocornea-intellectual disability syndrome is lifelong, and care focuses on regular eye checks, developmental support, and treatment for each person’s specific needs. Many living with Megalocornea-intellectual disability syndrome benefit from early intervention, vision care, and therapies that support communication, movement, and daily skills.
How many people live with Megalocornea-intellectual disability syndrome?
Worldwide and in the United States, there is no reliable population estimate for megalocornea-intellectual disability syndrome; rare disease sources describe it as ultra-rare, with only a handful of cases or families reported in the medical literature worldwide and no separate U.S. count (Orphanet, 2024; Genetic and Rare Diseases Information Center, 2024). Because so few people have been described, the exact number of people living with it is unknown in both places.
Overview
Megalocornea-intellectual disability syndromeSymptoms
Megalocornea-intellectual disability syndrome usually involves unusually large clear front eye surfaces, developmental delay, and learning difficulties. Many living with this condition also have low muscle tone, vision problems, and sometimes distinct facial features or coordination challenges.
Outlook and prognosis
People living with megalocornea-intellectual disability syndrome often need lifelong support for learning, vision, and daily tasks. Outlook depends on how strongly each feature affects them, but many benefit from early therapies, regular eye care, and steady family and school support.
Causes and risk factors
Megalocornea-intellectual disability syndrome is usually caused by a gene change present from early development. It may be inherited or happen for the first time in a child. Lifestyle and environmental factors do not cause it, but can affect complications.
Genetic influences
Genetics are central to Megalocornea-intellectual disability syndrome, which is usually caused by an inherited gene change. Different genetic variations can shape how strongly Megalocornea-intellectual disability syndrome affects the eyes, brain, and development.
Diagnosis
Megalocornea-intellectual disability syndrome is usually suspected from clinical features, especially very large corneas and developmental delay. Doctors often confirm the diagnosis with genetic tests. Eye exams and imaging may help rule out similar conditions.
Treatment and drugs
Megalocornea-intellectual disability syndrome is managed with regular eye care, glasses when needed, and monitoring for lens or pressure problems. Early speech, physical, and learning support can improve daily function. Treatment is tailored to each person’s needs.
Symptoms
Daily life may involve both vision differences and extra support for learning, movement, or communication. The early features of megalocornea-intellectual disability syndrome often include unusually large corneas, delayed development, and low muscle tone. For many people with megalocornea-intellectual disability syndrome, these features are present from infancy or early childhood, but the mix and severity can vary.
The clear front part of the eye is larger than usual, so the eyes may look unusually big or prominent from birth. This feature is often painless, but it is one of the main signs that leads to an eye evaluation.
Some people have blurry vision, strong nearsightedness, astigmatism, or sensitivity to light. In daily life, this can make reading, seeing a classroom board, or being outside in bright sun more difficult.
Babies and children often take longer to roll, sit, crawl, walk, or say first words. Families may notice that development moves forward, but at a slower pace and with more need for support.
Intellectual disability is a common feature, so learning, reasoning, and communication can take more time. Some children need ongoing help with speech, schoolwork, and daily routines such as dressing or following multistep instructions.
How people usually first notice Megalocornea-intellectual disability syndrome?
Megalocornea-intellectual disability syndrome is usually first noticed early in life, often when a baby or young child has unusually large, clear-looking eyes and a doctor finds that the front part of the eye, the cornea, is wider than expected. As children grow, families and clinicians may also notice delays in sitting, walking, talking, or learning, which become some of the first signs of Megalocornea-intellectual disability syndrome beyond the eye findings. Some children also have differences in muscle tone, coordination, or facial features, but the way the condition first shows up can vary from one child to another.
Types of Megalocornea-intellectual disability syndrome
No distinct types of megalocornea-intellectual disability syndrome are widely recognized.
Can I slow down the onset of symptoms?
For megalocornea-intellectual disability syndrome, there is no good evidence that lifestyle changes, diet, exercise, or medicines can meaningfully delay the start of symptoms, because this is a rare genetic condition that usually begins very early in life. What can help is early care: regular eye checks and early support for learning, development, and behavior can catch problems sooner and improve day-to-day functioning, but they do not prevent the condition or stop it from appearing. Even though the timing of symptoms usually cannot be changed, staying closely connected with the medical team can still make a real difference in comfort, safety, and development.
What genetics can tell you about symptoms
In megalocornea-intellectual disability syndrome, genetics can explain why a certain pattern of features tends to occur together, especially very large clear front parts of the eyes, developmental delay, and intellectual disability. Genetic differences may help shape how severe these features are and whether other problems are also present, but because this is a very rare condition, doctors usually cannot predict the exact symptoms, how serious they will be, or the age they will start based on genetics alone. Even within the same diagnosis, many living with this condition can have a range of symptoms and support needs.
Causes and risk factors
Megalocornea-intellectual disability syndrome usually happens because of a genetic change that affects development before birth. It may be passed down in a family, or it may happen for the first time in a child. The main risk factor is a family history of the condition, and risk can also be higher in families where parents are closely related. Lifestyle habits and environmental exposures are not known to cause this syndrome, though they can still affect general health and pregnancy outcomes. Researchers are still learning how these pieces fit together, and genetic testing may help some families understand the chance of it happening again.
What are the most common causes or risk factors?
Megalocornea-intellectual disability syndrome is thought to be mainly a genetic condition, meaning it is caused by a change in a gene that affects how the eyes and brain develop before birth. The main known risk factor is a family history of the condition or related features, because it can run in families and may be passed down from a parent. No common lifestyle, diet, or environmental risk factors have been clearly linked to it.
Environmental and biological risk factors
Megalocornea-intellectual disability syndrome is a congenital condition, and doctors have not identified clear environmental or non-genetic biological risk factors that are known to raise the chance of it occurring. Most known cases appear to begin from changes present at conception rather than from exposures later in pregnancy or daily life. Awareness of both biological and environmental influences helps you feel prepared, but for this condition the list of proven non-genetic risk factors is very limited.
Genetic risk factors
Families often want to know why this syndrome happened and whether it could happen again. The genetic causes of Megalocornea-intellectual disability syndrome are not fully understood, but the condition appears to have a strong inherited basis. Some risk factors are inherited through our genes. Reports from affected families suggest that more than one inheritance pattern may be possible, so the chance of it happening again can differ from one family to another.
Family history: Having a close relative with megalocornea, learning disability, or similar developmental differences makes a genetic cause more likely. In Megalocornea-intellectual disability syndrome, this kind of family pattern can help doctors estimate whether the condition may run in a family.
Recessive pattern: In some reported families, the syndrome appears to follow an autosomal recessive pattern, meaning a child inherits one altered gene copy from each parent. Parents are often healthy carriers and may not know they carry the change until a child is affected.
X-linked pattern: Other reported families suggest an X-linked pattern, where the gene change is on the X chromosome. This can make boys more likely to be affected, while mothers may be unaffected carriers or have milder features.
Unknown gene change: For many people with Megalocornea-intellectual disability syndrome, the exact gene change has still not been found. Because of this, genetic testing may not always confirm the diagnosis even when the signs strongly fit.
Lifestyle risk factors
Megalocornea-intellectual disability syndrome is not caused by lifestyle habits, but daily routines can still influence vision, development, comfort, and long-term function. When people ask about lifestyle risk factors for Megalocornea-intellectual disability syndrome, the key issue is usually how lifestyle affects Megalocornea-intellectual disability syndrome rather than what caused it. The most relevant factors are those that increase eye strain or injury, worsen developmental or behavioral difficulties, or make feeding, sleep, and mobility harder to manage.
Contact sports without protection, frequent eye rubbing, or poor supervision around hazards can increase the chance of eye injury in someone with enlarged corneas. Protective eyewear and habits that reduce trauma may help preserve vision and lower discomfort.
Long periods of intense screen use, poor lighting, or tasks that are not adapted to reduced visual function can worsen eye fatigue and daily frustration. A visually supportive environment with breaks and appropriate aids can improve comfort and participation.
Very low activity can worsen muscle weakness, coordination problems, reduced fitness, and loss of function that may already affect some people with this syndrome. Regular, supervised movement matched to ability can support balance, endurance, and independence.
Irregular sleep schedules or poor sleep habits can aggravate daytime irritability, inattention, and learning difficulties in people with intellectual disability. A consistent bedtime routine may improve behavior, participation, and overall quality of life.
Risk prevention
For Megalocornea-intellectual disability syndrome, true prevention of the condition itself is not usually possible because it is a genetic condition present from birth. Prevention mainly means lowering the risk of complications, supporting development, and spotting related health problems early. Some children may need regular eye, hearing, growth, and developmental follow-up so concerns are managed before they affect daily life more. Different people need different prevention strategies—there’s no single formula.
Families with Megalocornea-intellectual disability syndrome may benefit from genetic counseling before or during pregnancy. This can help clarify recurrence risk, testing options, and what to expect for future children.
Regular eye exams can help monitor megalocornea and related problems such as lens changes, glaucoma, or vision strain. Early treatment may help protect sight and make school and daily activities easier.
Early intervention with speech, physical, and learning support can help children with Megalocornea-intellectual disability syndrome build skills sooner. For many, this can mean better communication, movement, and day-to-day independence over time.
Some people with Megalocornea-intellectual disability syndrome may also have hearing problems, so periodic hearing testing can be important. Catching reduced hearing early can support language development and learning.
Can you prevent Megalocornea-intellectual disability syndrome?
No, there is no known way to prevent megalocornea-intellectual disability syndrome, because it is a rare genetic condition that starts before birth. If this condition has affected your family, meeting with a genetics specialist before pregnancy can help you understand the chance of it happening again and talk through testing options, but it cannot guarantee prevention.
Transmission
Megalocornea-intellectual disability syndrome is not contagious, so it cannot spread from one person to another through touch, coughing, kissing, sex, or shared food. Instead, the genetic transmission of Megalocornea-intellectual disability syndrome happens through gene changes that are present from conception.
In the families reported so far, it often appears to follow an autosomal recessive pattern, which means a child inherits one changed copy of the gene from each parent, while the parents are usually healthy carriers. Because this condition is very rare and the exact gene cause has not been confirmed in every family, how Megalocornea-intellectual disability syndrome is inherited can sometimes be unclear, and genetic counseling can help explain the chances for future children.
When to test your genes
Genetic testing is most useful when a child has megalocornea, developmental delay, or intellectual disability, especially if more than one family member is affected. A confirmed diagnosis can help tailor eye monitoring, developmental supports, and family counseling, but it is not a routine screening test for the general population.
Diagnosis
Diagnosis of Megalocornea-intellectual disability syndrome usually starts when a child has unusually large corneas along with developmental or learning concerns. Doctors usually begin with a careful exam and then use eye findings, growth and development history, and targeted testing to confirm the genetic diagnosis of Megalocornea-intellectual disability syndrome. Some diagnoses are clear after a single visit, while others take more time.
The doctor asks about early development, learning, speech, movement, and any vision concerns. A detailed family and health history can help show whether similar features have appeared in relatives or whether the condition seems to be new in the child.
An eye specialist measures the size of the cornea and checks for other eye differences that can look similar at first. This helps confirm true megalocornea and rule out more common causes of enlarged-looking eyes, such as childhood glaucoma.
Eye pressure is usually checked because raised pressure can also cause large eyes or corneal changes in children. Normal or near-normal pressure can help support this diagnosis when combined with the rest of the exam.
Doctors look at learning, language, behavior, and motor skills to understand the degree of intellectual disability or developmental delay. This can also help identify other support needs at home and school.
How is Megalocornea-intellectual disability syndrome diagnosed?
Doctors usually suspect megalocornea-intellectual disability syndrome when a child has unusually large clear front parts of the eyes, along with developmental delay, learning problems, and other features found during an eye exam and general medical checkup. The diagnosis is based mainly on this pattern of findings and on making sure the symptoms are not better explained by another eye condition or another cause of developmental problems. A DNA test may be used to look for the gene change linked to the syndrome and help confirm the diagnosis, but the exam, medical history, and development assessment are the main first steps.
Stages of Megalocornea-intellectual disability syndrome
Megalocornea-intellectual disability syndrome does not have defined progression stages. That is because it is usually recognized by a pattern of lifelong features, rather than a condition that moves through clear step-by-step phases over time. Doctors usually start with a conversation about development, learning, vision, and any health concerns, then add a physical exam and eye assessment to look for signs and symptoms of megalocornea-intellectual disability syndrome. Genetic testing may help confirm the diagnosis, and follow-up is usually based on a person’s needs, such as vision care, developmental support, and monitoring for related medical issues.
Outlook and prognosis
The outlook for people with megalocornea-intellectual disability syndrome is variable and depends on how severely vision, neurodevelopment, and any associated brain or body abnormalities are affected. Intellectual disability and developmental delay are usually lifelong, so most affected individuals need ongoing educational, behavioral, and supportive care, but the eye findings themselves are often nonprogressive or slowly changing. Visual function may remain useful, although some people develop additional ophthalmic problems such as refractive error, lens instability, glaucoma, or cataracts that can affect long-term vision and require regular monitoring. Because this is a very rare disorder, published data on life expectancy are limited, and there is no well-defined overall prognosis based on large studies. Mortality is not thought to be driven by megalocornea alone; when deaths occur, they are more likely related to severe associated congenital or neurologic complications rather than the eye enlargement itself. Early developmental intervention, regular ophthalmology follow-up, and management of coexisting medical issues offer the best chance to optimize function and quality of life.
Long-term effects
Many living with megalocornea-intellectual disability syndrome have lifelong differences that affect learning, vision, and day-to-day independence. The long-term picture is often shaped by how strongly these features affect each person, since the condition can vary from one individual to another. In childhood, developmental delays are often the most noticeable issue, while in adolescence and adulthood, ongoing support needs, vision changes, and behavioral or neurological features may matter more. It’s important to remember that long-term does not always mean steadily worsening, but many features can continue across life.
Intellectual disability is usually a long-term feature, and it can affect speech, school learning, problem-solving, and independent living. Some people need support with everyday tasks throughout life, while others gain skills more gradually over time.
Delays in sitting, walking, talking, or social development often begin early and can have lasting effects into later childhood and adult life. Over the years, many people learn that progress may continue, but at a slower pace than in other children.
Megalocornea means the clear front part of the eye is larger than usual, which can be linked with ongoing vision problems or eye strain. Some may find that focusing at school, reading, or judging distances stays difficult over time.
Some people with megalocornea-intellectual disability syndrome may develop additional eye concerns such as refractive errors, sensitivity to light, or other structural eye problems. Doctors may track these changes over years to see whether vision remains stable or needs closer monitoring.
How is it to live with Megalocornea-intellectual disability syndrome?
Living with megalocornea-intellectual disability syndrome often means managing a mix of vision needs and developmental challenges that can affect learning, communication, and day-to-day independence. Many people with this condition need regular eye care and may benefit from glasses or low-vision support, while intellectual disability can mean needing extra help with school, routines, safety, and transitions as they grow.
For families and other close supports, daily life may involve more appointments, more hands-on guidance, and more planning around education, therapies, and future care. At the same time, abilities can vary from one person to another, and with steady support, many living with this syndrome can build meaningful routines, relationships, and skills.
Treatment and drugs
Treatment for Megalocornea-intellectual disability syndrome is mainly supportive, which means care is guided by the symptoms each person has rather than by one single drug that treats the condition itself. Many living with Megalocornea-intellectual disability syndrome may need regular eye care, developmental support, and help with learning, speech, movement, or behavior, depending on how the condition affects daily life. Doctors sometimes recommend a combination of lifestyle changes and drugs, for example medicines for seizures, attention or behavior concerns, or sleep problems if these are present. Some may also benefit from glasses, low-vision support, physical therapy, occupational therapy, or special education services, especially when early support is started. Because Megalocornea-intellectual disability syndrome can vary from one person to another, treatment is usually coordinated by several specialists and adjusted over time as needs change.
Can you cure Megalocornea-intellectual disability syndrome?
No, there is no cure for megalocornea-intellectual disability syndrome at this time. Because it is caused by a change in genes, treatment cannot make it go away, but it can help manage eye problems, support learning and development, and treat other symptoms as they come up. Regular follow-up and services like vision care, physical therapy, speech support, and help at school can make daily life easier for many living with this condition.
Non-drug treatment
Day-to-day care for Megalocornea-intellectual disability syndrome usually centers on helping with vision, learning, communication, movement, and daily skills rather than on a single medical treatment. Because this condition can affect people in different ways, therapy is usually tailored to the child or adult’s strengths and needs. Supportive therapies can improve comfort, independence, and participation at home, school, and in the community.
Low-vision services, glasses when needed, and classroom adjustments can make reading, play, and moving around easier. For many living with Megalocornea-intellectual disability syndrome, this may mean brighter lighting, larger print, or sitting closer to the board.
Developmental programs in infancy and early childhood can help build motor, language, and social skills step by step. This is often one of the most helpful early treatments for Megalocornea-intellectual disability syndrome.
Speech and language therapy can support talking, understanding, and nonverbal communication. If speech is very limited, therapists may suggest picture systems or speech devices so everyday needs are easier to express.
Occupational therapy helps with dressing, feeding, handwriting, play, and other daily tasks. Some may find sensory strategies or adaptive tools useful when busy environments or fine-motor tasks feel hard.
Your genes may have an impact on how drugs work for you
For people living with megalocornea-intellectual disability syndrome, medicines are usually chosen to treat day-to-day problems such as seizures, behavior or mood concerns, sleep trouble, or issues around eye care, and inherited differences can sometimes affect how strongly a medicine works or how likely side effects are. In real life, this can mean one person gets good control with a usual dose while another seems extra sleepy, irritable, or gets little benefit from the same treatment. There is no well-established gene-based prescribing guide that is specific to this syndrome, so doctors usually adjust medicines based on symptoms, side effects, and careful follow-up rather than a standard genetic drug test.
Pharmacological treatments
There is no single medicine that treats megalocornea-intellectual disability syndrome itself, so drug treatment is usually aimed at specific symptoms or related health problems. For many, this can mean a mix of medicines over time rather than one fixed plan. Not everyone responds to the same medication in the same way. Care is often coordinated across eye care, neurology, and developmental specialists.
If seizures are part of megalocornea-intellectual disability syndrome, doctors usually treat them with standard anti-seizure medicines such as levetiracetam, valproate, lamotrigine, or oxcarbazepine. The choice depends on seizure type, age, side effects, and any other health issues.
Some people with megalocornea-intellectual disability syndrome may be prescribed medicines for severe irritability, aggression, or self-injury, most often risperidone or aripiprazole. These drugs do not treat the underlying syndrome, but they can sometimes make daily life and learning more manageable.
When hyperactivity or inattention is causing major problems, medicines such as methylphenidate, amphetamine-based stimulants, atomoxetine, guanfacine, or clonidine may be considered. Finding the right medication can be a process of trial, patience, and adjustment.
Sleep problems may be treated with melatonin, especially if trouble falling asleep is adding to daytime behavior or fatigue. In some children, improving sleep can also ease some early symptoms of megalocornea-intellectual disability syndrome that affect attention and mood.
Genetic influences
When a child has unusually large corneas along with learning and developmental challenges, genetics appear to play a major role in Megalocornea-intellectual disability syndrome. It’s natural to ask whether family history plays a role. Reported cases suggest that, in at least some families, Megalocornea-intellectual disability syndrome may be inherited in a recessive way, meaning both parents can carry the same gene change without being affected themselves and still have an affected child. At the same time, the exact gene cause has not been clearly confirmed for every family, so genetic testing for Megalocornea-intellectual disability syndrome may not always give a definite answer. A genetics specialist can help review family history, explain the chance of the condition happening again in the family, and discuss whether testing of the child and parents is likely to be useful.
Is Megalocornea-intellectual disability syndrome genetic?
Genetics are central to Megalocornea-intellectual disability syndrome, which is usually caused by an inherited gene change. Different genetic variations can shape how strongly Megalocornea-intellectual disability syndrome affects the eyes, brain, and development.
Having a genetic risk is not necessarily a diagnosis
It is normal for people to have genetic variants, and these variants are common in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are part of the picture. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Megalocornea-intellectual disability syndrome, care is shaped less by one single drug and more by the mix of vision, learning, and other health needs they have. Because this condition starts with an underlying genetic change, genetic testing can help confirm the diagnosis, guide follow-up with the right specialists, and show which related problems may need watching over time. Not every difference in response is genetic, but in Megalocornea-intellectual disability syndrome, the genetic diagnosis can help doctors avoid unnecessary testing and tailor care to the symptoms that are actually present. There is no established medicine that corrects the genetic cause itself, so treatment for Megalocornea-intellectual disability syndrome usually focuses on supportive care, such as eye care, developmental supports, and medicines only when specific related symptoms need them. If medications are needed, doctors usually choose them based on the individual’s symptoms, age, and overall health rather than on a known drug-response pattern that is specific to this syndrome.
Interactions with other conditions
For many living with megalocornea-intellectual disability syndrome, the main overlap is not with a long list of separate diseases, but with conditions that can add to vision, learning, and daily care challenges. The enlarged clear front part of the eye seen in this syndrome can look similar to other eye disorders, especially childhood glaucoma, so doctors usually make sure those conditions are not being missed because the treatment needs are different. Some people with megalocornea-intellectual disability syndrome may also have seizures or low muscle tone, and when these are present they can make school, communication, balance, and independence harder. Day-to-day, it can feel like one health issue amplifies the other, such as poor vision making developmental delays more noticeable or seizures interrupting progress with therapies. There is no well-established pattern showing that megalocornea-intellectual disability syndrome directly causes a broad range of other diseases, but supportive care often involves several specialties because the eye, brain, and developmental features can affect each other. Open communication with healthcare providers helps when eye care, neurology, and developmental support all need to fit together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Megalocornea-intellectual disability syndrome?
The main conditions doctors usually think about are congenital glaucoma, which can make a baby’s eyes or the clear front part of the eye look unusually large, and isolated megalocornea, where the cornea is large but there are no major learning or developmental problems. Some other rare genetic conditions can also combine eye differences with developmental delay, so doctors often look at the whole picture, including vision, growth, muscle tone, and learning, before making the diagnosis.
History
Families usually begin with the day-to-day questions: why are the eyes unusually large, why is vision being monitored so closely, and why are learning or developmental differences happening at the same time. What is now called Megalocornea-intellectual disability syndrome was not recognized all at once. Instead, doctors first noticed recurring patterns in a small number of children and adults whose eye findings appeared alongside developmental and cognitive challenges.
Initially understood only through symptoms, later reports helped show that these features could belong to the same condition rather than being separate, unrelated problems. Earlier medical descriptions focused heavily on what could be seen during an eye exam, especially the enlarged clear front part of the eye, because that was often the most striking clue. As more people were described in the medical literature, clinicians began to see a broader picture that could also include delayed milestones, differences in muscle tone, and varying degrees of intellectual disability.
This gradual recognition mattered because early symptoms of Megalocornea-intellectual disability syndrome can overlap with other developmental or eye conditions, which made diagnosis harder in the past. Over time, improved eye imaging, pediatric assessments, and more careful follow-up allowed doctors to distinguish Megalocornea-intellectual disability syndrome from other causes of large corneas or developmental delay. Researchers later identified that the syndrome has a genetic basis, which helped confirm that the eye and brain-related features were connected.
The history of Megalocornea-intellectual disability syndrome is still relatively short compared with more common conditions, largely because it is rare and many older cases may not have been fully recognized. Even so, the medical understanding has become clearer with each reported family and each carefully documented case. For people living with Megalocornea-intellectual disability syndrome today, that growing history means doctors are better able to recognize the condition, explain what it may involve, and guide families toward the right eye care, developmental support, and follow-up.